Evidence map›Paper›PMID 41283247›Full record

ReviewMedical sciences (Basel, Switzerland)2025

Nuclear CaMKII Isoforms as Regulators of Transcription: From Developmental to Pathological Persistence.

Areli Marlene Gaytán-Gómez, Claudio Adrián Ramos-Cortés, Ricardo Xopan Suarez-García, Diego Alberto Martínez-Islas, Axel Tonatiuh Marroquin-Aguilar, Fernanda Avelino-Vivas, Dafne Montserrat Solis-Galván, Alexis Arturo Laguna-González, Bruno Manuel García-García, Eduardo Minaya-Pérez and 7 more

Abstract readReview
In one paragraph

Review in Medical sciences (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Nuclear Proteome Map of Mouse Heart Chambers.Molecular & cellular proteomics : MCP · 2026
    Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Areli Marlene Gaytán-GómezUnidad de Remisión de Diabetes Mellitus (URDM), Facultad de Estudios Superiores-Iztacala, Universidad Nacional Autónoma de México, Tlalnepantla 54090, Mexico.
Claudio Adrián Ramos-CortésUnidad de Remisión de Diabetes Mellitus (URDM), Facultad de Estudios Superiores-Iztacala, Universidad Nacional Autónoma de México, Tlalnepantla 54090, Mexico.
Ricardo Xopan Suarez-GarcíaUnidad de Remisión de Diabetes Mellitus (URDM), Facultad de Estudios Superiores-Iztacala, Universidad Nacional Autónoma de México, Tlalnepantla 54090, Mexico.
Diego Alberto Martínez-IslasUnidad de Remisión de Diabetes Mellitus (URDM), Facultad de Estudios Superiores-Iztacala, Universidad Nacional Autónoma de México, Tlalnepantla 54090, Mexico.
Axel Tonatiuh Marroquin-AguilarUnidad de Remisión de Diabetes Mellitus (URDM), Facultad de Estudios Superiores-Iztacala, Universidad Nacional Autónoma de México, Tlalnepantla 54090, Mexico.
Fernanda Avelino-VivasUnidad de Remisión de Diabetes Mellitus (URDM), Facultad de Estudios Superiores-Iztacala, Universidad Nacional Autónoma de México, Tlalnepantla 54090, Mexico.
Dafne Montserrat Solis-GalvánUnidad de Remisión de Diabetes Mellitus (URDM), Facultad de Estudios Superiores-Iztacala, Universidad Nacional Autónoma de México, Tlalnepantla 54090, Mexico.
Alexis Arturo Laguna-GonzálezUnidad de Remisión de Diabetes Mellitus (URDM), Facultad de Estudios Superiores-Iztacala, Universidad Nacional Autónoma de México, Tlalnepantla 54090, Mexico.
Bruno Manuel García-GarcíaUnidad de Remisión de Diabetes Mellitus (URDM), Facultad de Estudios Superiores-Iztacala, Universidad Nacional Autónoma de México, Tlalnepantla 54090, Mexico.
Eduardo Minaya-PérezUnidad de Remisión de Diabetes Mellitus (URDM), Facultad de Estudios Superiores-Iztacala, Universidad Nacional Autónoma de México, Tlalnepantla 54090, Mexico.
Efren Quiñones-LaraDepartamento de Biomedicina Molecular, Centro de Investigación y de Estudios Avanzados del Instituto Politécnico Nacional (CINVESTAV-IPN), Ciudad de Mexico 07360, Mexico.ORCID 0000-0001-5577-0908
Axel Eduardo Muciño-GaliciaCarrera de Médico Cirujano, Facultad de Estudios Superiores-Iztacala, Universidad Nacional Autónoma de México, Tlalnepantla 54090, Mexico.
Olga Villamar-CruzUnidad de Biomedicina (UBIMED), Facultad de Estudios Superiores Iztacala, Universidad Nacional Autónoma de México, Tlalnepantla 54090, Mexico.
Luis Enrique Arias-RomeroUnidad de Biomedicina (UBIMED), Facultad de Estudios Superiores Iztacala, Universidad Nacional Autónoma de México, Tlalnepantla 54090, Mexico.ORCID 0000-0001-5676-2483
Sonia León-CabreraUnidad de Biomedicina (UBIMED), Facultad de Estudios Superiores Iztacala, Universidad Nacional Autónoma de México, Tlalnepantla 54090, Mexico.ORCID 0000-0002-1661-5013
Leonel Armas-LópezUnidad de Biomedicina (UBIMED), Facultad de Estudios Superiores Iztacala, Universidad Nacional Autónoma de México, Tlalnepantla 54090, Mexico.ORCID 0000-0001-9490-4294
Héctor Iván Saldívar-CerónUnidad de Remisión de Diabetes Mellitus (URDM), Facultad de Estudios Superiores-Iztacala, Universidad Nacional Autónoma de México, Tlalnepantla 54090, Mexico.ORCID 0000-0002-9125-9100

Funding

This research was funded by the Consejo Mexiquense de Ciencia y Tecnología (COMECYT), grant numbers FICDTEM-2023-131 (awarded to H.I.S.-C.) and by the Universidad Nacional Autónoma de México (UNAM), through grants PAPIIT IA201725 and PAPIME 203825 (H.I.S. FICDTEM-2023-131, PAPIIT IA201725 and PAPIME 203825
6 · The paper itself

Abstract

Calcium/calmodulin-dependent protein kinase II (CaMKII) comprises multiple isoforms with distinct nuclear variants that exert transcriptional control in a context-dependent manner. Among them, CaMKIIδB and δ9 in the heart, and CaMKIIγ in the nervous system, have emerged as regulators of chromatin dynamics, transcription factor activity, and developmental gene programs. Nuclear localization is driven by splice-dependent nuclear localization sequences, with phosphorylation at defined serine residues modulating import and retention. Evidence supports CaMKII-dependent phosphorylation of class IIa HDACs (Ser467/Ser632 in HDAC4), linking CaMKII to MEF2 activation in cardiac hypertrophy, and interactions with NF-κB and HSF1 further expand its nuclear repertoire. In the nervous system, CaMKIIγ contributes to kinase-dependent gene expression, potentially influencing plasticity and disease susceptibility. While these mechanisms highlight nuclear CaMKII as an isoform-specific regulator of transcription, direct evidence remains elusive, and several CaMKII putative substrates require further validation. This review synthesizes current knowledge on nuclear CaMKII isoforms, emphasizes established mechanistic pathways, and outlines unsolved questions critical for understanding their roles in development, disease progression, and therapeutic targeting.

Indexed as

Calcium-Calmodulin-Dependent Protein Kinase Type 2Cell NucleusTranscription, GeneticAnimalsHumansIsoenzymesPhosphorylationProtein IsoformsCalcium-Calmodulin-Dependent Protein Kinase Type 2IsoenzymesProtein Isoformsalternative splicingcalcium-calmodulin-dependent protein kinase IIcell nucleusgene expression regulationgenetictranscription

Identifiers

PMID41283247
PMCPMC12642011

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.